RxDoctor Payments Data

Michael Verdon, DO

Neurological Surgery · Dayton, OHNPI 1427276948

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Avanos Medical at 44.1% of the total. Reporting peaked in 2022 at $21,158 and has fallen 73.5% since, to $5,601 in 2025.

$46,203in general payments, 2019–2025

Across 146 payments — averaging $316.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanos Medical$20K
  • Choice Spine, LLC$8K
  • Clariance, Inc.$5K
  • Nanohive Medical LLC$4K
  • Arthrex$2K
  • Medicrea USA, Corp.$2K
  • plus $7K from 22 others

What the payments were for

  • Consulting fees$10,67523%
  • Speaking & faculty fees$20,24444%
  • Travel & lodging$9,70921%
  • Food & beverage$4,0209%
  • Education$1,3653%
  • Gifts$1900%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,203 in reported general payments places this provider in the 85th percentile of 301 neurological surgery providers in Ohio.

See all neurological surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$39,180
Medicare patients
99
Services billed
259

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$348
Celecoxib16$292
Gabapentin26$149
Diclofenac Sodium11$130
Methylprednisolone15$79

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →